| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| azd2624 | neuromedin-k receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] Multiple Sclerosis[MeSHID:D009103] |
17.36 | phase 2 | antagonist |
| azd2624 | neuromedin-k receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] Multiple Sclerosis[MeSHID:D009103] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||